Cibiltech
Predict4Health is a healthcare technology company specializing in predictive medicine to prevent organ failure and improve patient outcomes. Their business model centers on providing AI-driven predictive algorithms and digital health platforms for clinicians, researchers, and patients, including products like Predigraft for physicians, Apilife for patient telemonitoring, and Predigraft Research for pharmaceutical clinical trials. The company leverages the iBox technology, a universal predictive algorithm for transplantation developed by the Paris Transplant Group, to offer personalized, data-driven decision support that enhances graft survival and patient care. Predict4Health has achieved significant clinical traction with over 500 patients recruited in ongoing iBox clinical trials and holds CE marking for its medical device solutions, positioning it as a leader in predictive transplant medicine with a global user base and integration capabilities in hospital IT systems.
Cibiltech
Predict4Health is a healthcare technology company specializing in predictive medicine to prevent organ failure and improve patient outcomes. Their business model centers on providing AI-driven predictive algorithms and digital health platforms for clinicians, researchers, and patients, including products like Predigraft for physicians, Apilife for patient telemonitoring, and Predigraft Research for pharmaceutical clinical trials. The company leverages the iBox technology, a universal predictive algorithm for transplantation developed by the Paris Transplant Group, to offer personalized, data-driven decision support that enhances graft survival and patient care. Predict4Health has achieved significant clinical traction with over 500 patients recruited in ongoing iBox clinical trials and holds CE marking for its medical device solutions, positioning it as a leader in predictive transplant medicine with a global user base and integration capabilities in hospital IT systems.
TL;DR
Headquarters: Paris, Île-de-France, France
Founded: 2019-02-02
Product focus: AI-driven predictive medicine for renal transplantation
Notable regulatory/clinical status: CE marking reported for medical device solutions
Recent funding signal: Grant from NHS England (Mar 2023)
Company Overview
Problem Domain
Predictive medicine for renal transplantation (graft-loss prediction and clinical decision support).
Founded
2019
Industry
Healthtech / Predictive medicine
Funding Track Record
Reported grant round listed on company funding summaries.
Reported as non-equity assistance program participation.
Investor Signal
“NHS England grant support and participation in DigitalHealth.London Accelerator reported”